Concepedia

Brigitte Nault

BN

6

Publications

991

Citations

6

H-Index

2000

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Brigitte Nault is an author at Novartis (Switzerland) specializing in medicine, gastroenterology, and pharmacology.

Top concepts

Publications per year

2000–2015

6

Publications

6

Tegaserod, a 5‐HT<sub>4</sub> receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

S. Müller‐Lissner, I. Fumagalli, Karna Dev Bardhan et al. · Alimentary Pharmacology & Therapeutics · 2001 · 464 citations · Full text

Tegaserod for the Treatment of Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled Multinational Study

Michael A. Kamm, S. Müller‐Lissner, Nicholas J. Talley et al. · The American Journal of Gastroenterology · 2005 · 197 citations

Effect of tegaserod in chronic constipation: A randomized, double-blind, controlled trial

John F. Johanson, Arnold Wald, Gervais Tougas et al. · Clinical Gastroenterology and Hepatology · 2004 · 180 citations

, , +8

Long‐term safety of tegaserod in patients with constipation‐predominant irritable bowel syndrome

Gervais Tougas, W.J. Snape, M.H. Otten et al. · Alimentary Pharmacology & Therapeutics · 2002 · 77 citations

, , +16

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic <scp>HCV</scp> genotype 1 infection (<scp>ESSENTIAL II</scp>)

Stefan Zeuzem, Robert Flisiak, John M. Vierling et al. · Alimentary Pharmacology & Therapeutics · 2015 · 41 citations · Full text

Rows per page

1–5 of 6